The Legal 500 EMEA 2020 Recommends Lidings Among Top Legal Advisor in Russia
April 15th 2020 the new edition of The Legal 500 EMEA, international ranking for the best law firms and individual lawyers from over 150 jurisdictions, is launched.
April 15th 2020 the new edition of The Legal 500 EMEA, international ranking for the best law firms and individual lawyers from over 150 jurisdictions, is launched.
Chambers and Partners Europe has announced the results of its annual research of the leading legal advisors. Lidings is traditionally highly recommended for Dispute Resolution, Corporate and M&A, and Life Sciences advice in Russia.
A new ranking for the world’s best law firms and individual lawyers annually provided by The Legal 500 EMEA once again confirms Lidings position as one of the strongest legal advisors in corporate and M&A and dispute resolution in Russia.
Lidings once again takes top positions as the leading legal advisor in the areas of Dispute Resolution, Corporate and M&A, and Life Sciences in Russia as a result of the best law firms’ research annually conducted by Chambers and Partners Europe.
Best Lawyers, an international legal directory annually identifying the most prominent lawyers around the world by analyzing their professional skills and achievements during the year, as well as their business reputation based on the feedback of peers from their respective jurisdictions, once again lists Lidings’ Managing Partner Andrey Zelenin and Partner Tatiana Bicheva among the best lawyers in Russia in four key practice areas.
A new ranking for the world’s best law firms and individual lawyers annually provided by The Legal 500 EMEA continues to rank Lidings among the strongest legal advisors in corporate law, mergers and acquisitions, real estate and construction, and dispute resolution in Russia.
The results of the best law firms’ research annually conducted by Chambers and Partners Europe once again demonstrate Lidings’ top positions as the leading legal advisor in the areas of Dispute Resolution, Corporate and M&A, and Life Sciences in Russia.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.